[18F] Florquinitau

N/A

Report date: 2025/11/26 17:11:31
NME

Base Information

Drug Name[18F] Florquinitau
Drug Alias NameFluorine 18 MK 6240Florquinitau (18F)[18F]MK-6240
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsCognitive DysfunctionPrediabetic StateDiabetes Mellitus, Type 2 +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesCerveau Technologies IncNihon Medi-Physics Co LtdProthena Corp Plc +[8] 
Inactive CompaniesLumind Idsc FoundationMerck Sharp & Dohme LLC
Active IndicationsCognitive DysfunctionPrediabetic StateDiabetes Mellitus, Type 2 +[4] 
Inactive IndicationsDown Syndrome

Other Information

ATC CodeN/A
Related LinksN/A